EUROFINS SCIENT Net Income/Loss 2018-2024 | ERFSF
EUROFINS SCIENT annual/quarterly net income/loss history and growth rate from 2018 to 2024. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
- EUROFINS SCIENT net income/loss for the quarter ending December 31, 2024 was $0.600B, a 13.95% decline year-over-year.
- EUROFINS SCIENT net income/loss for the twelve months ending December 31, 2024 was $2.911B, a 48.5% increase year-over-year.
- EUROFINS SCIENT annual net income/loss for 2024 was $0.6B, a 30.99% increase from 2023.
- EUROFINS SCIENT annual net income/loss for 2023 was $0.458B, a 44.25% decline from 2022.
- EUROFINS SCIENT annual net income/loss for 2022 was $0.822B, a 34.26% decline from 2021.
| EUROFINS SCIENT Annual Net Income/Loss (Millions of US $) |
|
|---|---|
| 2024 | $600 |
| 2023 | $458 |
| 2022 | $822 |
| 2021 | $1,250 |
| 2020 | $793 |
| 2019 | $304 |
| 2018 | $342 |
| 2017 | $283 |
| 2016 | $0 |
| 2015 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.897B | $7.522B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.067B | 27.09 |
| CVS Health (CVS) | United States | $78.811B | 9.80 |
| Elevance Health (ELV) | United States | $66.101B | 8.89 |
| Cencora (COR) | United States | $56.558B | 19.68 |
| DiDi Global (DIDIY) | China | $24.238B | 25.75 |
| Labcorp Holdings (LH) | United States | $22.089B | 17.43 |
| Natera (NTRA) | United States | $19.248B | 0.00 |
| ICON (ICLR) | Ireland | $14.657B | 14.10 |
| CochLear (CHEOY) | Australia | $13.278B | 0.00 |
| Solventum (SOLV) | United States | $12.626B | 13.37 |
| Medpace Holdings (MEDP) | United States | $12.299B | 32.55 |
| Revvity (RVTY) | United States | $10.708B | 18.58 |
| Viatris (VTRS) | United States | $10.563B | 3.63 |
| Avantor (AVTR) | United States | $9.404B | 13.66 |
| Sonic Healthcare (SKHHY) | Australia | $8.886B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.654B | 16.96 |
| HealthEquity (HQY) | United States | $8.544B | 37.42 |
| Bausch + Lomb (BLCO) | Canada | $4.851B | 32.64 |
| Amplifon S.p.A (AMFPF) | Italy | $3.871B | 21.19 |
| Sotera Health (SHC) | United States | $3.382B | 19.22 |
| GeneDx Holdings (WGS) | United States | $2.953B | 68.10 |
| Surgery Partners (SGRY) | United States | $2.867B | 37.28 |
| Concentras Parent (CON) | United States | $2.615B | 15.11 |
| Organon (OGN) | United States | $2.610B | 2.77 |
| Alignment Healthcare (ALHC) | United States | $2.572B | 0.00 |
| Progyny (PGNY) | United States | $2.014B | 44.34 |
| Premier (PINC) | United States | $1.772B | 13.45 |
| GoodRx Holdings (GDRX) | United States | $1.747B | 34.93 |
| PACS (PACS) | United States | $1.710B | 0.00 |
| Ardent Health (ARDT) | United States | $1.528B | 6.51 |
| Teladoc Health (TDOC) | United States | $1.298B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.213B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.065B | 8.10 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.791B | 0.00 |
| CareDx (CDNA) | United States | $0.716B | 11.18 |
| AMN Healthcare Services Inc (AMN) | United States | $0.712B | 6.67 |
| Embecta (EMBC) | United States | $0.611B | 4.11 |
| So-Young (SY) | China | $0.501B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.479B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.471B | 0.00 |
| Nutex Health (NUTX) | United States | $0.467B | 7.06 |
| LifeMD (LFMD) | United States | $0.459B | 0.00 |
| Omada Health (OMDA) | $0.455B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.455B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.454B | 10.23 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.369B | 0.00 |
| Enhabit (EHAB) | United States | $0.338B | 27.83 |
| Oncology Institute (TOI) | United States | $0.329B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.270B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Sera Prognostics (SERA) | United States | $0.108B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.096B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| KindlyMD (NAKA) | United States | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.017B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.013B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |